TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ConvaTec ( (GB:CTEC) ) just unveiled an update.
ConvaTec Group PLC has executed a share buyback program, purchasing 1,812,238 ordinary shares as part of a previously announced $300 million initiative. The shares, bought at an average price of 236.42 pence, will be held in treasury, impacting the company’s share capital structure and potentially benefiting shareholders by increasing the value of remaining shares.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score is driven primarily by its strong financial performance, characterized by consistent revenue growth and solid profitability. Technical analysis indicates a moderate upward trend, although valuation metrics suggest the stock may be overvalued. The absence of earnings call insights and corporate events limits additional context.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products and technologies industry, focusing on products and services for advanced wound care, ostomy care, continence and critical care, and infusion devices. The company is dedicated to improving the lives of people with chronic conditions and aims to enhance its market presence through strategic initiatives.
Average Trading Volume: 7,003,975
Technical Sentiment Signal: Buy
Current Market Cap: £4.65B
For detailed information about CTEC stock, go to TipRanks’ Stock Analysis page.